
Tazocef 250mg/31.25mg Injection
Marketer
Medley Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Tazocef 250mg/31.25mg Injection
Ceftazidime/Tazobactam 250mg/31.25mg injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial growth and propagation. Administration must be overseen by a medical professional. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement. Premature cessation may compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Allergic reactions (such as rash, pruritus, edema, or dyspnea) require prompt emergency care. Inform your physician of all concurrent medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Tazocef 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Tazocef 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Tazocef 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Tazocef 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazocef 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam injection (250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering bacterial growth. Tazobactam counteracts bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Tazocef 250 mg/31.25 mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Tazocef 250 mg/31.25 mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Tazocef 250 mg/31.25 mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administering Tazocef 250 mg/31.25 mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Tazocef 250 mg/31.25 mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Tazocef 250 mg/31.25 mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Tazocef 250 mg/31.25 mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Tazocef 250mg/31.25mg Injection :
Omitting a scheduled dose of Tazocef 250 mg/31.25 mg Injection necessitates contacting your physician.
Facts to Know About Tazocef 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
